Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
1.533
0.00 (0.00%)
Dec 26, 2024, 3:00 PM EST

Nuo Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-2.48-3.17-3.17-0.09-0.09-1.19
Upgrade
Depreciation & Amortization
0.090.110.07--0.09
Upgrade
Other Amortization
----0.020.1
Upgrade
Loss (Gain) From Sale of Assets
-----0.02
Upgrade
Stock-Based Compensation
0.030.020.010.010.330.05
Upgrade
Provision & Write-off of Bad Debts
0.080.16----
Upgrade
Other Operating Activities
0.030.02-0.15--0.33-
Upgrade
Change in Accounts Receivable
-0.17-0.32-0.09--0.02
Upgrade
Change in Inventory
0.010.01-0.24--0.03
Upgrade
Change in Accounts Payable
-0.02-00.020.01-0.030.1
Upgrade
Change in Other Net Operating Assets
0.010.01-0.16-0.050.04-0.13
Upgrade
Operating Cash Flow
-2.41-3.17-3.71-0.12-0.05-0.92
Upgrade
Capital Expenditures
-0.15-0.01-0.06---
Upgrade
Investing Cash Flow
-0.15-0.01-0.06---
Upgrade
Short-Term Debt Issued
-----0.31
Upgrade
Total Debt Issued
-----0.31
Upgrade
Net Debt Issued (Repaid)
-----0.31
Upgrade
Issuance of Common Stock
2.6124.461.370.2-
Upgrade
Financing Cash Flow
2.6124.461.370.20.31
Upgrade
Miscellaneous Cash Flow Adjustments
-0-0----
Upgrade
Net Cash Flow
0.05-1.180.691.250.14-0.62
Upgrade
Free Cash Flow
-2.57-3.18-3.77-0.12-0.05-0.92
Upgrade
Free Cash Flow Margin
-219.94%-521.76%-3355.12%---630.52%
Upgrade
Free Cash Flow Per Share
-0.06-0.08-0.09-0.00-0.00-0.04
Upgrade
Cash Interest Paid
0.0100--0.07
Upgrade
Levered Free Cash Flow
-1.51-1.85-2.74-0.09-0-0.23
Upgrade
Unlevered Free Cash Flow
-1.51-1.85-2.74-0.090.01-0.23
Upgrade
Change in Net Working Capital
-0.07-0.010.680.040.09-0.23
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.